NEW AP104 Recognizing the High-Risk “Benign” Endometrial Biopsy
2:00–5:30 pm
3.0 CME CREDITS
Nonmalignant endometrial biopsies and curettages, frequent components of any busy surgical pathology practice, often present difficult diagnostic challenges due to artifact and morphologic variation amongst individual entities. This course will present practical approaches to resolve commonly encountered diagnostic thresholds with immediate clinical management implications. Topics will include metaplasias—benign or high risk?; hyperplasias—hormonal effect or precancer?; things you can miss if you do not think of them; useful special studies; and hints for managing the indeterminate case. This course will pay special attention to sampling problems in a fragmented specimen format, the modifying effects of hormonal environment on interpretation, and those diagnostic thresholds that correspond to clinical management decisions.
You will learn to:
- Identify unusual presentations of commonly encountered nonneoplastic specimens, including sampling and interpretive limitations in their diagnosis
- Describe the features of premalignant endometrium and its distinction from benign mimickers and carcinoma
- Resolve benign, premalignant, and malignant subsets of endometrial metaplasias and hyperplasia
- Describe uses of special studies in common diagnostic settings
- Understand the clinical implications of common pathologic diagnoses
Faculty
George L. Mutter, MD, FCAP
Marisa R. Nucci, MD, FCAP
Cosponsored by 